134 related articles for article (PubMed ID: 10753850)
1. Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.
Ponzanelli I; Giannì M; Giavazzi R; Garofalo A; Nicoletti I; Reichert U; Erba E; Rambaldi A; Terao M; Garattini E
Blood; 2000 Apr; 95(8):2672-82. PubMed ID: 10753850
[TBL] [Abstract][Full Text] [Related]
2. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.
Mologni L; Ponzanelli I; Bresciani F; Sardiello G; Bergamaschi D; Gianní M; Reichert U; Rambaldi A; Terao M; Garattini E
Blood; 1999 Feb; 93(3):1045-61. PubMed ID: 9920855
[TBL] [Abstract][Full Text] [Related]
3. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
Giannì M; de Thé H
Leukemia; 1999 May; 13(5):739-49. PubMed ID: 10374879
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
5. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.
Marchetti P; Zamzami N; Joseph B; Schraen-Maschke S; Méreau-Richard C; Costantini P; Métivier D; Susin SA; Kroemer G; Formstecher P
Cancer Res; 1999 Dec; 59(24):6257-66. PubMed ID: 10626821
[TBL] [Abstract][Full Text] [Related]
6. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway.
Hsu CA; Rishi AK; Su-Li X; Gerald TM; Dawson MI; Schiffer C; Reichert U; Shroot B; Poirier GG; Fontana JA
Blood; 1997 Jun; 89(12):4470-9. PubMed ID: 9192771
[TBL] [Abstract][Full Text] [Related]
7. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
Oncogene; 1999 Apr; 18(14):2357-65. PubMed ID: 10327056
[TBL] [Abstract][Full Text] [Related]
10. New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation.
Kitamura K; Kiyoi H; Yoshida H; Tobita T; Takeshita A; Ohno R; Naoe T
Cancer Chemother Pharmacol; 1997; 40 Suppl():S36-41. PubMed ID: 9272132
[TBL] [Abstract][Full Text] [Related]
11. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
12. Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid.
Zhang Y; Huang Y; Rishi AK; Sheikh MS; Shroot B; Reichert U; Dawson M; Poirer G; Fontana JA
Exp Cell Res; 1999 Feb; 247(1):233-40. PubMed ID: 10047465
[TBL] [Abstract][Full Text] [Related]
13. Synthetic retinoid CD437 induces apoptosis of esophageal squamous HET-1A cells through the caspase-3-dependent pathway.
Wan X; Duncan MD; Nass P; Harmon JW
Anticancer Res; 2001; 21(4A):2657-63. PubMed ID: 11724335
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424
[TBL] [Abstract][Full Text] [Related]
15. Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Chandraratna RA; Tesfaigzi Y; Hong WK; Lotan R
Mol Pharmacol; 2000 Sep; 58(3):508-14. PubMed ID: 10953043
[TBL] [Abstract][Full Text] [Related]
16. Proliferation-dependent induction of apoptosis by the retinoid CD437 in p53-mutated keratinocytes.
Wanner R; Henseleit-Walter U; Wittig B; Kolde G
J Mol Med (Berl); 2002 Jan; 80(1):61-7. PubMed ID: 11862326
[TBL] [Abstract][Full Text] [Related]
17. Evidence supporting a role for mitochondrial respiration in apoptosis induction by the synthetic retinoid CD437.
Hail N; Youssef EM; Lotan R
Cancer Res; 2001 Sep; 61(18):6698-702. PubMed ID: 11559538
[TBL] [Abstract][Full Text] [Related]
18. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
19. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.
Pisano C; Kollar P; Gianní M; Kalac Y; Giordano V; Ferrara FF; Tancredi R; Devoto A; Rinaldi A; Rambaldi A; Penco S; Marzi M; Moretti G; Vesci L; Tinti O; Carminati P; Terao M; Garattini E
Blood; 2002 Nov; 100(10):3719-30. PubMed ID: 12393712
[TBL] [Abstract][Full Text] [Related]
20. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells.
Sun SY; Yue P; Lotan R
Oncogene; 2000 Sep; 19(39):4513-22. PubMed ID: 11002424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
